Merck Kgaa · XETR:MRK
Merck Kgaa — Merck KGaA, Darmstadt, Germany — ESG Presentation (March 2025)
101 slides from Merck Kgaa's sustainability presentation, March 2025
Slide 1: Sustaining life for generations
Sustaining life for generations Sustainability @ Merck KGaA, Darmstadt, Germany Investor Relations Darmstadt, March 2025
Slide 2: Disclaimer
Disclaimer Publication of Merck KGaA, Darmstadt, Germany. In the United States and Canada the group of companies affiliated with Merck KGaA, Darmstadt, Germany operates under individual business names (EMD Serono, Millipore Sigma, EMD Performance Materials). To reflect such fact and to avoid any mis
Slide 3: Strategy & Ambition
Strategy & Amibition Sustainability strategy Sustainability goals Focus areas
Slide 4: Group: Scientific exploration and responsible entrepreneurship
Scientific exploration and responsible entrepreneurship: Sparking discovery, elevating humanity Group As a leading science and technology company, we In Healthcare, we help to believe in science as a force for create, improve and prolong Healthcare good. We uniquely combine lives worldwide with thre
Slide 5: Goals and focus areas reflecting our sustainability ambition
3 Goals and 7 focus areas reflecting our sustainability ambition Products 01 02 03 People & Planet Processes Partnering for Dedicated to Reducing our sustainable business human progress ecological footprint impact In 2030, we will achieve human progress By 2030, we will fully integrate By 2040, we w
Slide 6: Significant achievements on our way to reach our ambitious targets
Significant achievements on our way to reach our ambitious targets Products: Access to Health for all Intention Ambition Tablets of praziquantel Expand emerging markets’ Positive impact on 2,2 bn1 delivered to endemic access to our products health and well-being 2023 countries achievement People: Di
Slide 7: Agenda for sustainable development: Where we can make the biggest difference
Agenda for sustainable development: Where we can make the biggest difference Good health & well-being Responsible consumption & production With our products, we create a positive impact on the We use resources efficiently health and quality of life of and reduce waste and people around the world. Em
Slide 8: Accelerated science & tech leadership driving growth and sustainability
Accelerated science & tech leadership driving growth and sustainability Economic growth can drive progress, create decent jobs and improve 21.2 bn 6.1 bn ~62,500 39% 141 65 living standards Net sales1 EBITDA pre1 Employees1 Women in Nationalities Countries Leadership1 Good health & wellbeing at all
Slide 9: Sustainable innovation as strategic pillar for future business growth
Sustainable innovation as strategic pillar for future business growth Reducing the upstream footprint for our customers More sustainable products Environmental progress ahead of Green Speed Quantification Tool for our customers schedule reduces impact: measures impact for customers: ▪ Scope 1+2 emis
Slide 10: Impact on People
Impact on People Goals Targets Initiatives
Slide 11: Goal 1: Dedicated to Human Progress
Goal 1: Dedicated to Human Progress Sustainable innovations and technology for our customers We believe that we can harness science and technology to help tackle many global challenges. Impact of our products on health and well-being At least half of the world’s population still does not have adequa
Slide 12: Performing above industry average
Performing above industry average: 7th Group ranks 7th in Access to Medicine index ▪ We leverage our expertise and collaborate with communities and strong 6th in R&D partners to develop solutions for patients in developing healthcare systems: Above average with structured access planning, integrat
Slide 13: Access to Health – a focused leadership approach
Access to Health – a focused leadership approach Expand access to Catalyze innovative Fight infectious our healthcare solutions for global diseases for the portfolio in LMICs1 health challenges most vulnerable ▪ Shortening gap ▪ R&D engine to ▪ We aim to ▪ Donation between global deliver integrated
Slide 14: Integrated strategies to fight schistosomiasis and malaria
Integrated strategies to fight schistosomiasis and malaria We aim to eliminate the worm We help deliver integrated disease schistosomiasis health solutions against malaria ▪ Health education for behavioral change: ▪ Help prevent the spread of malaria by supporting water, sanitation and hygiene Trans
Slide 15: Life Science: Enabling our customers to reduce environmental impact
Life Science: Enabling our customers to reduce environmental impact ➢ Program to foster sustainable ➢ Products and enabling tools product development for sustainable science and pharma Design for Sustainability (DfS) DOZN 2.0 ▪ With the DfS program, we aim to reduce environmental ▪ Evaluates the rel
Slide 16: More sustainable products in EL
More sustainable products in EL Advancing sustainable digital living: Our approach Collaboration Innovation Operation We work within the value chain to We consider sustainability as a As a major supplier to the collectively introduce more core aspect of our technology electronics industry, we are su
Slide 17: Diversity, Equity, Inclusion & Belonging
Diversity, Equity, Inclusion & Belonging A clear focus on equity and inclusivity when we do business DEIB in clinical trials 1 Partner with healthcare providers that treat traditionally underserved racial & ethnic populations to ensure comprehensive patient representation when developing treatments.
Slide 18: DEIB Policy
Providing a diverse and inclusive environment We deeply care for the people working for us, as well as the communities we operate in. ➢ We are convinced that diversity, equity and inclusion drive progress and innovation, and are good for business. ➢ We have advanced organizational maturity: All busi
Slide 19: Impact on Nature
Impact on Nature Goals Targets Initiatives
Slide 20: Goal 3: Reducing our ecological footprint
Goal 3: Reducing our ecological footprint Doing our part to help mitigate climate change Climate protection and energy efficiency will pay off in the long run – for the environment and our business. Striving to use our resources as efficiently as possible We aim to conserve and recycle water and red
Slide 21: Reduce our environmental footprint: Emissions, Water and Waste
Reduce our environmental footprint: Emissions, Water and Waste Goal Climate neutrality Enhance water Reduce waste 3 by 2040 efficiency & purity impact ▪ Lower scope 1+2 GHG3 ▪ Enhancing water efficiency: ▪ Until 2030, we aim to emissions by -50%4 -50% reduction of water achieve a Circularity intake
Slide 22: Target on water efficiency
Target on water efficiency: Improve ratio of water intake per revenues by 50% until 2030 Metric Scope Water intake water intake (m³) Total water intake of the company. = ratio revenue (m€) All sites and types of water use included. 800 792 ▪ Full view on Group’s water use: 679 589 576 588 ▪ Scope ex
Slide 23: Target on waste and recycling
Target on waste and recycling: Achieve a circularity rate of 70% until 2030 Metric Scope Circularity recycled waste + avoided waste = Production Waste. All sites included. rate total waste1 80% ▪ New target allows each sector to contribute in the most impactful way 75% Goal: 70% ▪ Excluding waste-to
Slide 24: Responsible use of natural resources
Responsible use of natural resources Scope 1+2 GHG emissions: 80% of purchased electricity from Circularity Rate4 of 70% kt -50% absolute reduction by 2030 1,2 renewable sources by 2030 for the whole company 2152 1951 100% 80% 2.000 1760 80% Goal: 80% 75% 1463 1.500 70% 69,2% Goal: 70% 1085 60% 47%
Slide 25: GHG target
Scope 1+2 emissions nearly halved, 2030 reduction target expected to be achieved ahead of schedule Scope 1+2 vs. sales Scope 1: Reduction of -30.6% to 858 kt in 20242 ▪ Successful roll-out of NF3 reduction technology CO2 equivalents Sales drove target achievement to 49.7% reduction in 2024 vs. 2020
Slide 26: Company is committed to the Green Deal
Company is committed to the Green Deal and contributes by achieving its climate goals SBTi1 near-term target Climate neutrality target Green Deal net-zero 2030 2040 requirement by 2050 Effect of all reportable Effect of all reportable Effect of all reportable Scope greenhouse gas emissions2 greenhou
Slide 27: Energy management: Investing in green energy
Energy management: Investing in green energy % Electricity purchased from GWh2 purchased electricity mix 100% 80% ambition renewable sources incl. business 2022 vs. 2026e 90% growth 80% ~70%3 2022 2026e incl. new VPPAs Spain 70% Texas 2025e 2022 60% 52% 47% 51% Conventional Conventional Texas 50% el
Slide 28: Water quality target
Water quality target: Process for reduction of residues in wastewater on track 2030: 2021 2022 2023 2024 2025 2026 2027 2028 2029 No harmful residues in Step 1: Identify relevant sites wastewater 100% 2024: 20% of relevant sites with Ilustration, internal estimates Step 2: Identify relevant substanc
Slide 29: Turn the impact on biodiversity from negative to positive
Turn the impact on biodiversity from negative to positive Group‘s Group‘s Influence on conservation impact Group’s targets and actions supporting the general long-term of ecosystems today principles of the Convention on Biological Diversity ambition ▪ Reduce emissions to support 1.5°C warming limit
Slide 30: Improved packaging to reduce environmental footprint
Reduce the impact on the environmental footprint of our products by improved packaging SMASH packaging: We strive to maximize our impact by driving more systematic and data-driven packaging sustainability improvements. Shrink – reduce amount of packaging Save – maximize recycling ➢ Eliminate the use
Slide 31: Governance
Governance Targets & numbers Reporting Risk Management Supply Chain Policies Ratings
Slide 32: Goal 2: Partnering for sustainable business impact
Goal 2: Partnering for sustainable business impact Sustainability in our ways of working & decision making Our people and communities: providing a diverse and inclusive environment Sustainable and transparent supply chain Our supplier management focuses on high-quality, delivery reliability, and com
Slide 33: Clear metrics to drive execution towards 2030 ambition
Clear metrics to drive execution towards 2030 ambition Goal Metric 2024 (2023) Target 1 Percentage of newly published patent families with positive sustainability impact 34% (29%1) n.a. People treated with our Healthcare products* 184 mio (177 mio) 1 bn people ambition2 Pharma products enabled by Li
Slide 34: Diverse human capital: Thinking, talking, and leading differently
Diverse human capital: Thinking, talking, and leading differently Indicator Status Focus areas Aspirations 2024 (2023) Gender parity Gender Percentage of women in leadership globally 39% (39%) until 2030 Percentage of underrepresented ethnic Increase to 30% 24% (23%) colleagues in US leadership unti
Slide 35: Steering sustainability goals by targeted investments
Steering to achieve our sustainability goals by targeted investments Investment categories incorporating sustainability aspects R&D Sustainability Scorecard to prioritize R&D R&D projects leading to more sustainable Our sustainability products, e.g. Design for Sustainability in guardrails are an Lif
Slide 36: Decisions in R&D affect the value chain & sustainability goals
Decisions in R&D affect the value chain & sustainability goals Vision: 1 Using our innovation power to accelerate Dedicated Dedicated toto sustainability goals of human progress human progress • Merck KGaA, Darmstadt, Germany In 2030, we will achieve human progress for more than one billion • Our pa
Slide 37: Our vision for sustainable portfolio management
Our vision for sustainable portfolio management: From R&D to commercial 99% M-spot Roll-out of of all R&D sustainability project product assessments assessments in completed all 3 sector in 2023 2023 portfolios in In-house tool to automate sustainability in the manufacturing processes of chemical pr
Slide 38: Sustainability in the Supply Chain: sustainable procurement
Sustainability in the Supply Chain Our approach to sustainable procurement What we expect: Supplier expenditure as % and ➢ Integration of at least fundamental number of suppliers per region1 environmental and social standards, in 2023 addition to high-quality, reliable delivery and competitive price
Slide 39: Supply chain management supporting the overarching goals
Sustainability in the Supply Chain Supply chain management supporting the overarching goals Partnering for 02 Reducing our 03 sustainable business impact ecological footprint Sustainable and transparent Climate change supply chain and emissions Prevent violations of Supplier supply chain standards &
Slide 40: Progress in supplier sustainability assessments
Sustainability in the Supply Chain Targets on track: Progress in supplier sustainability assessments Sustainability assessments in our supply chain 94% 94% 92% ▪ Relevant suppliers: suppliers in risky countries and industries 75% 73% 82% + suppliers accounting for 50% of Group purchase volume 66% 65
Slide 41: Effective sustainability governance structures and frameworks
Effective sustainability governance structures and frameworks Adherence to main codes, principles, CEO + ESG in standards, and frameworks, e.g.: Overall sustainability 1 member of Supervisory responsibility Executive Board Board: Audit • UN Global Compact & UN Guiding Principles Committee on Busines
Slide 42: Supplier Decarbonization Program
Supplier Decarbonization Program: Join forces with our suppliers for greener products Challenges and approach towards supplier decarbonization: Extensive and diverse supply chain ➔ Focus on main contributors Low awareness in some regions of the world ➔ Create awareness, Supplier Code of Conduct Data
Slide 43: Animal Welfare: Driving animal-free methods in research
Animal Welfare: Driving animal-free methods in research Our long-term aspiration: Phase out animal testing by providing better solutions to guide science Develop framework and Businesses to Group in a leading Group to position as standards on animal develop strategic position and go-to the innovatio
Slide 44: Innovation comes with responsibility: Ethical guidance
Innovation comes with responsibility: Ethical guidance Governance Internal & - Two external committees of international leading experts External who give recommendations on biological and digital ethical issues. Guidelines - Serving as guardrails for our behavior and entrepreneurial actions ✓ Group
Slide 45: Transparency on sustainability progress following major standards
Transparency on sustainability progress following major standards Mandatory Annual Report Non-financial Compensation EU reporting incl. Corporate statement Report Taxonomy Governance Report TCFD Science-based Reporting target Other Referring to SASB Reporting standards GRI Standards for all 3 sector
Slide 46: External stakeholders assess our engagement
External stakeholders assess our engagement Improved 2025 Since 2022, Company is Company received a Since 2008, Company is part In the ISS corporate ESG1 receiving a MSCI ESG1 Sustainalytics ESG1 Risk of FTSE4Good Index, ranking Company achieved Rating of AAA. Rating of 15.5, measuring the performan
Slide 47: Investor Relations contacts
FLORIAN SCHRAEDER NADJA GROSSCHMIDT SUSAN KUEHN Head of Investor Relations Assistant Investor Relations Assistant Investor Relations +49 6151 72-5271 +49 6151 72-3321 +49 6151 72-3321 [email protected] [email protected] [email protected] PETER DICKSON ADRIAN GORSKI G
Slide 48: Deep Dive
Deep Dive Examples & initiatives Governance details
Slide 49: Governance: Company's ownership structure
Governance Company‘s ownership structure Shareholders E. Merck KG, Darmstadt, Germany: of Merck KGaA, Darmstadt, Germany Partners‘ Meeting & Family Board ▪ Shareholders hold ~30% of Company’s total capital ▪ E. Merck KG, Darmstadt, Germany (99.9% Family) holds ▪ Share capital is divided into 129,242
Slide 50: Proposed compensation system changes from 2026
Most important changes for the proposed compensation system from 2026 Current system (since 2021) New: 2026 compensation system Profit sharing: Profit sharing: ▪ 3-years performance period ▪ 1-year performance period ▪ Minimum threshold €0.75 bn profit after tax ▪ Minimum threshold €1.5 bn profit af
Slide 51: Governance: Executive compensation 2024
Governance Executive compensation 2024 virtual Group share units Company Long-term incentive plan Profit sharing Pension entitlements Additional benefits Basic compensation 51 ESG | 2024
Slide 52: Executive Board long-term incentive linked to sustainability
Executive Board long-term incentive is linked to sustainability ▪ Since fiscal year 2022, our sustainability strategy will be even more firmly embedded in the compensation system for the members of the Executive Board ▪ The sustainability factor encompasses three performance criteria according to th
Slide 53: Sustainable dividend growth
Sustainable dividend growth 2,50 * 25,00 2,20 2,20 2,20 Dividend Development1 22,23 20,99 2,00 2010-2024 19,69 1,85 20,00 17,53 1,50 16,15 1,40 Dividend Policy2 15,33 1,25 1,25 1,30 15,02 1,20 14,84 1,05 15,00 Company aims to continuously 1,00 1,00 0,85 0,95 12,85 develop dividends in line with 0,
Slide 54: Group sustainability strategy: Deep dive into strategic focus areas
Group sustainability strategy: Deep dive into strategic focus areas Sustainability innovation and technology Sustainability in our ways of working & for our customers decision making Sustainability as integral part of product design Safe & ethical research, ethical & compliant Enable customers
Slide 55: Successful business with positive impact on environment and society
Successful business with positive impact on environment and society Supervision, steering and consulting Executive Board, Supervisory Board, Sustainability Board (int.), Sustainability Advisory Panel (ext.) Sustainability Reduce our negative Help customers to reduce Greener in all functions impact n
Slide 56: Sustainable Business Value (SBV): Measuring impact of action
Sustainable Business Value (SBV): Measuring impact of action First use cases across Environment Economic value B2C & B2B calculated, e.g. Environmental sustainability of Generated for society and economy company’s operations, products and from company activities, products services and services Liqui
Slide 57: Ready for the German Supply Chain Due Diligence Act
Supply chain management Ready for the German Supply Chain Due Diligence Act Satisfy the whishes and expectations of customers, investors and authorities on a WHY ? sustainable and transparent supply chain Risk analysis Preventive Mitigation Complaint measures actions systems WHAT ? Social & environm
Slide 58: Access to health & global health
Access to health & global health A focused leadership approach to access for health in LMICs1 Pipeline Conduct assessment for LMICs to ensure Future Launches: LMIC launch & access plans are in place Go faster for upcoming launches New Innovative Brands: Increase number of LMICs with availability, Go
Slide 59: World Animal Day: Northern White Rhino
Generating positive impact by usage of our innovations Further hope to save the Northern White Rhino October 4th ▪ Northern White Rhino suffered for decades on illegal World Animal Day hunting of their horns leaving only two female Northern White Rhinos left ▪ Collaboration with conservationists and
Slide 60: How to anchor decarbonization within our organization
How to anchor decarbonization within our organization Integrating climate targets Making sustainability into CapEx process e.g. (including GHG internal CO2 price emissions) part of the R&D process Enablers of decarbonization Implement technical Linking climate targets requirements for GHG1 and execu
Slide 61: Decisive levers to reaching our near-term target
Decisive levers to reaching our near-term target – progress on track Scope 1&2: Scope 1: Main lever NF3 process emissions [kt CO2e] • Technical abatement solution successfully piloted for NF3 2,500 -50% • Investment for retrofitting existing plants earmarked 2,028 • Future capacity expansions only w
Slide 62: Our community engagement activities in 2024
Our community engagement activities in 2024 ➢ Supporting the communities in which our sites are located ▪ In designing our projects, we are guided by ▪ Group Policy on Contributions to Society ▪ Access to Health Charter ▪ WHO guidelines for medicine donations ▪ Corporate Volunteering Guideline ▪ In
Slide 63: Sustainability at Merck KGaA, CMD 2024
Sustainability at Merck KGaA, Darmstadt, Germany Sustainability Team CMD 2024 in Darmstadt, Germany October 17, 2024 12:30 pm – 1:30 pm
Slide 64: CMD 2024: ESG Session
CMD 2024: ESG Session Highlighting our sustainability actions Global Health & Health Equity Sustainability Harald in the Supply Nusser Diversity, Chain Ethics in Equity, Jorge Petra Governance Bandenay Inclusion & Wicklandt & Operations Belonging Renee Jean Enno Connolly Charton Jeffrey Sustainable
Slide 65: Sustainability Strategy update
Sustainability Strategy update Petra Wicklandt Head of Corporate Sustainability, Quality and Trade Compliance
Slide 66: Strategy review confirming our overall goals
Sustainability Strategy Update Strategy review confirming our overall goals Highlighting need for Stronger focus on social Including circular economy, animal business integration aspects of sustainability welfare and biodiversity as strategic Products People & topics Planet Processes 66 CMD 20
Slide 67: New water and waste targets
Sustainability Strategy Update New water and waste targets Previous targets for water and waste achieved ahead of schedule New water intensity target related to net sales (previously working hours) New waste goal includes circularity to emphasize focus on new strategic area of circular economy
Slide 68: Significant achievements on our way to reach our ambitious targets
Sustainability Strategy Update Significant achievements on our way to reach our ambitious targets Products: Access to Health for all Intention Ambition Tablets of praziquantel Expand emerging markets’ Positive impact on 2 bn1 delivered to endemic access to our products health and well-being 2023 cou
Slide 69: Sustainability regulation (CSRD) implementation
Sustainability Strategy Update Sustainability regulation (CSRD1) implementation well on track Transparent non-financial reporting Successful completion of materiality analysis to gain a solid foundation New digital data infrastructure will enable automized and high-quality non-financial data process
Slide 70: Ethics in Governance and operations
Ethics in Governance and operations Jean Enno Charton Director Bioethics & Digital Ethics
Slide 71: Data Ethics/AI & Bioethics: Enabling responsible innovation
Ethics in Governance & Operations Data Ethics/AI & Bioethics: Enabling responsible innovation ▪ Breakthrough innovations open new, unregulated fields: Developing these innovations responsibly, even before new regulations are established, fosters long-term trust and sustainable business success. ▪ As
Slide 72: Ethics in the decision-making process: our governance
Ethics in Governance & Operations Ethics in the decision-making process: our governance ▪ Since most bioethical questions arose within Healthcare, the sector professionalized its approach in 2011 by establishing an advisory panel of leading academic bioethicists to guide innovation. ▪ Recommendation
Slide 73: Digital ethics: Becoming a thought leader
Ethics in Governance & Operations Digital ethics: Becoming a thought leader through operationalization Since 2019, Group has increasingly faced questions about responsible data handling and AI: ▪ Data: Despite regulations, unethical or trust-damaging practices can still occur within legal boundaries
Slide 74: Diversity, Equity, Inclusion, Belonging
Diversity, Equity, Inclusion, Belonging Renee Connolly Chief Diversity, Equity & Inclusion Officer and Head of Innovation HR Engagement & Inclusion
Slide 75: DEIB Policy
Diversity, Equity, Inclusion & Belonging Providing a diverse and inclusive environment We deeply care for the people working for us, as well as the communities we operate in. ➢ We are convinced that diversity, equity and inclusion drive progress and innovation, and are good for business. ➢ We have a
Slide 76: Progress towards our ambition to be an industry leader in DE&I
Diversity, Equity, Inclusion & Belonging Progress towards our ambition to be an industry leader in DE&I Purposeful Our commitments Our aspirations EOY for 2030 2023 actions Gender equity have led to significant Gender parity in 39% We are aiming at gender parity leadership positions progress in lead
Slide 77: A clear focus on equity and inclusivity
Diversity, Equity, Inclusion & Belonging A clear focus on equity and inclusivity when we do business DEIB in clinical trials 1 Partner with healthcare providers that treat traditionally underserved racial & ethnic populations to ensure comprehensive patient representation when developing treatments.
Slide 78: Sustainability in the Supply Chain
Sustainability in the Supply Chain Jorge Bandenay Head of Sustainable Procurement
Slide 79: Our approach to sustainable procurement
Sustainability in the Supply Chain Our approach to sustainable procurement What we expect: Supplier expenditure as % and ➢ Integration of at least fundamental number of suppliers per region1 environmental and social standards, in 2023 addition to high-quality, reliable delivery and competitive price
Slide 80: Supply chain management supporting the overarching goals
Sustainability in the Supply Chain Supply chain management supporting the overarching goals Partnering for 02 Reducing our 03 sustainable business impact ecological footprint Sustainable and transparent Climate change supply chain and emissions Prevent violations of Supplier supply chain standards &
Slide 81: Progress in supplier sustainability assessments
Sustainability in the Supply Chain Targets on track: Progress in supplier sustainability assessments Sustainability assessments in our supply chain 94% 94% 92% ▪ Relevant suppliers: suppliers in risky countries and industries 75% 73% 82% + suppliers accounting for 50% of Group purchase volume 66% 65
Slide 82: Global Health & Health Equity
Global Health & Health Equity Harald Nusser Head of Global Health & Health Equity
Slide 83: Applying the concept of Health Equity across the value chain
Global Health & Health Equity Applying the concept of Health Equity across the value chain Driving Health Equity starts with ensuring communities have access Manufacturing Health system strengthening Equitable pricing to quality care and are provided the Supply chain Digital health Patient assistanc
Slide 84: Multi-stakeholder partnerships as a crucial lever
Global Health & Health Equity Multi-stakeholder partnerships as a crucial lever The right partnerships help accelerate the progress and success of our programs, ultimately serving our goal of improving population health. Key collaborations Our partners Description/overview Impact creation ▪ Pediatri
Slide 85: Schistosomiasis: Driving progress in elimination efforts
Global Health & Health Equity Schistosomiasis: Driving progress in countries' elimination efforts Enhancing treatment and Our strategy towards morbidity control & production options elimination as a public health problem ▪ Obtaining WHO prequalification for a new ▪ Partnerships with external funders
Slide 86: More Sustainable Products in LS
More Sustainable Products in LS Jeffrey Whitford Vice President Sustainability & Social Business Innovation, Life Science
Slide 87: Expanding our bio-based solvent portfolio
More Sustainable Products in LS Expanding our bio-based solvent portfolio Delivering climate targets, meeting tightening regulatory action and helping customers reduce their footprint. By 2030, we aim to fully convert all conventional solvents to bio-based alternatives in our portfolio wherever feas
Slide 88: Design for Sustainability in Process Solutions
More Sustainable Products in LS Design for Sustainability in Process Solutions Millistak®+ HC Pro Micro clarification devices The first more sustainable product from Process Solutions since we fully embedded ❖ 75% less plastic sustainability into the product ❖ 230% lower global warming potential for
Slide 89: Customer Sustainability Dashboard
More Sustainable Products in LS Customer Sustainability Dashboard Taking the guesswork out of customer 220+ customer interactions sustainability with data-driven, actionable on sustainability in 2023 solutions ▪ Identify opportunities to reduce customers’ footprint through purchasing decisions inclu
Slide 90: More Sustainable Products in EL
More Sustainable Products in EL Miriam Tolksdorf Head of Sustainability & Safety, Electronics
Slide 91: Advancing sustainable digital living: Our approach
More sustainable products in EL Advancing sustainable digital living: Our approach Collaboration Innovation Operation We work within the value chain to We consider sustainability as a As a major supplier to the collectively introduce more core aspect of our technology electronics industry, we are su
Slide 92: Collaboration & innovation for sustainable digital progress
More sustainable products in EL Collaboration & innovation for sustainable digital progress Low GWP Etch Gases SURE* Scorecard Digital Solutions NF3 Abatement R&D solutions for process gases with We are embedding the assessment We aim to strengthen the use of Reducing our greenhouse gas excellent qu
Slide 93: Collaboration for a more sustainable industry
More sustainable products in EL Collaboration for a more sustainable industry Leverage knowledge and research expertise to identify Multistakeholder new and more sustainable Academic research Data Analytics Initiatives solutions Evaluation study on program leveraging Platform unlocking low emission
Slide 94: Update on Climate Action
Update on Climate Action Andreas Polomski Head of Climate Action
Slide 95: Group is committed to achieving its climate goals
Climate Action Group is committed to achieving its climate goals SBTi1 near-term target Climate neutrality target Green Deal net-zero 2030 2040 requirement by 2050 Effect of all reportable Effect of all reportable Effect of all reportable Scope greenhouse gas emissions2 greenhouse gas emissions2 gre
Slide 96: Reduction of GHG emissions on track
Climate Action Reduction of GHG emissions on track Scope 1+2 vs. sales Scope 1 reduction (-18.6% to 1,236 kt in 20232): ▪ Currently, NF3 reduction technology roll-out to CO2 equivalents Sales sustainably reduce emissions from production ▪ First full-scale central NF3 reduction capability technology
Slide 97: Setting the course towards climate neutrality
Climate Action Setting the course towards climate neutrality Strategic and governance Anchoring in organization prerequisites Develop net zero Refine carbon shadow price in 1 6 Further strengthen customer and supplier decision making collaboration transition plan (CSRD1) 2 Targets & Enable corporate
Slide 98: Circular Economy
Circular Economy Till Langner Head of Sustainability Incubation & Innovation
Slide 99: Identifying CE solution areas with highest potential impact
Circular Economy Identifying the CE solution areas with the highest potential impact Demands: Regulations, investors, ESG rating agencies Sourcing & Research & Transport & procurement design distribution Suppliers Material Customers Packaging Sales & use Patients Upstream Midstream Downstream Energy
Slide 100: Development of circular products and business models
Circular Economy Development of circular products and business models Our approach and strategic plan Product-related CE examples ➢ Develop sector-specific and Group-wide Cyrene CE strategy as an integral part of the Biobased solvent (made from renewable sustainability strategy. resource − cellulose
Slide 101: CE aspects embedded in our sustainability strategy
Circular Economy CE aspects are deeply embedded in our sustainability strategy Goals Focus areas CE contribution Sustainable innovations and Dedicated technologies for our customers ▪ Integrating circular design indicators to Human into our R&D process. Progress Impact of our products on health and
Merck KGaA, Darmstadt, Germany — ESG Presentation (March 2025) on 6ix